Tablets & Capsules


Issue link:

Contents of this Issue


Page 31 of 53

Monday's events include a round- table on the role of biorelevant dissolution specifications in patient outcomes. Mini-symposia cover ex pe - diting drug development via "break - through therapies" designation, as well as advances in prescription drug- abuse deterrence. Tuesday begins with a sunrise ses- sion on pharmicokinetic modeling in drug development. Mini-symposia address combination products and innovations in drug delivery systems; establishing your brand; and design and control of API powder properties to optimize manufacturing. Longer symposia cover open-innovation drug discovery and using in vivo studies to improve in vitro models for oral drug delivery. On Wednesday, discussion topics include excipients as atypical actives; chemistry, potency, and drug dosing; and natural products with medicinal benefits for women's health. Thurs - day's sessions look at the evolving regulatory landscape for complex delivery and release dosage forms. T&C Exhibitors The following companies and orga- nizations are among those exhibiting at the AAPS Annual Meeting.Advertisers in this issue are listed in boldface. For a complete, updated list, visit www.aaps. org/ AMExhibit. a preview San Diego, CA, is the site for the 2014 American Association of Phar - ma ceutical Scientists (AAPS) annual meeting and exposition. From No - vember 2-6, leaders and decision- makers from academia and industry gather to network and share insights on current research, technology, and methodology. Pharma science researchers will present more than 2,500 scientific papers and posters. More than 500 supplier companies are exhibiting their products, equip- ment, publications, and services at the 4-day exposition beginning Sunday evening. Conference Educational sessions begin Sunday with short courses on topics such as materials science and modeling approaches for designing robust com- bination tablets; and the clinical, non- clinical, and CMC components essen- tial to a global New Drug Application. All-day workshops look at improvements in oral bioavailability via lipid-based delivery and the safety and regulatory challenges of botanical drug products and dietary supplements. From 4:30 to 6:30 pm, physician-scientist and inventor Daniel Kraft provides the keynote address on innovations in medicine powered by new tools, tests, and applications that deliver diagnostic information to the patient. AAPS Annual Meeting & Exposition AAPS comes to San Diego with an emphasis on technological innovation Company Booth A ACG North America 2204 AAI Pharma Services Corp 1243 Abitec 716 Advantest 2751 Agere Pharmaceuticals 1249 Almac 3050 Ashland Specialty Ingredients 2223 B BASF 2723 Bosch Packaging Technology 3711 Brookfield Engineering 3921 Buchi 324 C CapsCanada 3621 Capsugel 1422 Catalent Pharma Solutions 1414 Coating Place 3311 Colorcon 1023 CoreRx 423 D DFE Pharma 2317 Dissolution Technologies 3335 Distek 2517 E Elizabeth 318 Evonik 1123 F Fette Compacting 914 Fluid Imaging Technologies 2306 Freund-Vector 2821 G Gamlen Tableting 3612 Gateway Analytical 3404 Gattefossé 722 Glatt Air Techniques 914 30 September 2014 Tablets & Capsules

Articles in this issue

Archives of this issue

view archives of Tablets & Capsules - TC0914